REVOLUTIONS IN INJECTABLES

Industry leaders and innovators convene to decode the future of injectable therapies and showcase India's growing strength in high-value injectables

- 

Inaugural Session

The Injectable Innovations Conclave 2025 brought together leading minds to explore the next frontier in injectable drug delivery. The conclave featured breakthrough technologies, real-world case studies and thought-provoking discussions on manufacturing excellence, regulatory readiness, and the role of digital transformation in enhancing injectable therapies.

It began with a welcome address by Viveka Roychowdhury, Editor of Express Pharma, Express Healthcare, and Express Nutra, who outlined the vision behind the conclave. She highlighted the immense growth potential in the injectables market, driven by an aging global population, the increasing burden of chronic diseases, supportive policy shifts, and the wave of patent expirations opening up new opportunities for generics.

The welcome address was followed by the ceremonial lamp lighting, a moment that symbolised the official start of this knowledge-sharing initiative. Roychowdhury was joined by a distinguished group of industry leaders and partners.

Keynote Address: Reimagining Injectables: Patient. Precision. Planet

Dr Pavan Bhat, CEO, Inventia Healthcare, set the tone for the day with a compelling presentation on the need to reimagine injectables through the lens of patient-centricity, technological precision, and environmental sustainability.

Dr Bhat emphasised that injectables are the lifeline of modern medicine, holding a dominant position in critical care, biologics, and vaccines. However, their growing importance is hindered by inherent challenges like working with fragile molecules, complex formulations, and the integration of increasingly sophisticated delivery devices.